Dicerna Pharmaceuticals Inc. (Nasdaq: DRNA) and Alynylam Pharmaceuticals Inc. (Nasdaq: ALNY) settled a stolen trade secrets case. Shares of Dicerna Pharmaceuticals soared $1.82 to close at $12.01 while Alnylam Pharmaceuticals' stock gained $1.29 to close at $97.48.